Cinvop

Aprepitant

Indication
prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy.

Class
neurokinin-1 antagonist

Pack Size
Combo Pack

Available Strength
125mg 1’s & 80mg 2’s Capsule